Overview

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the effects of enoxaparin on bleeding and venous blood clots in patients with hip fracture surgery.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sanofi
Treatments:
Enoxaparin
Criteria
Inclusion Criteria:

- femoral neck inside or outside fracture

Exclusion Criteria:

- any major surgery on lower limbs within 3 months

- clinical signs of deep vein thrombosis

- use of non-steroidal anti-inflammatory drugs

- severe hepatic disease or renal insufficiency